BillionToOne Patents

Patent portfolio assigned to BillionToOne (verified via public assignee records). Molecular diagnostics / NIPT (UNITY) and liquid biopsy (US; founded 2016; IPO 2025). Confirmed patent assignee 'BillionToOne Inc' on Google Patents (e.g. US12043873B2, US10577655B2) plus Illumina NIPT patent lawsuit; exact count not verified. Sold to clinicians/OB-GYNs, no single named customer org confirmed from own site.